{"id":31442,"date":"2014-09-18T09:17:19","date_gmt":"2014-09-18T13:17:19","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=31442"},"modified":"2014-09-18T09:17:19","modified_gmt":"2014-09-18T13:17:19","slug":"auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442","title":{"rendered":"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) Bid"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/18\/2014 (wallstreetpr) \u2013 <strong>Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)<\/strong> confirmed yesterday that <strong>Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP)<\/strong> gave an unsolicited buyout offer for the acquisition of former. Meanwhile, Auxilium Pharmaceuticals has also adopted the <a href=\"http:\/\/online.wsj.com\/articles\/auxilium-confirms-endo-bid-adopts-shareholder-rights-plan-1410954510?mod=yahoo_hs\" target=\"_blank\"><strong>shareholder rights plan<\/strong><\/a>.<\/p>\n<p style=\"text-align: justify;\"><strong>A lot of suitors<\/strong><\/p>\n<p style=\"text-align: justify;\">The company had earlier agreed that it will merge with <strong>QLT Inc. (USA) (NASDAQ:QLTI)<\/strong>, a biotechnology firm based in Canada. Auxilium Pharmaceuticals is still going ahead with its merger plan with Canadian Biotech Company. But, as far as the bid from\u00a0Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) is concerned, Auxilium said that it will consider the offer for review. Meanwhile, it also said that the company\u2019s Board will not change or retract from the merger recommendation with QLT.<\/p>\n<p style=\"text-align: justify;\">Auxilium had announced about the merger deal with QLT in June 2014. Giving nod to\u00a0Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) to go ahead with the Endo deal, QLT also gave its consent to the shareholder-rights plan. Also,\u00a0QLT Inc. (USA) (NASDAQ:QLTI) reaffirmed its backing to Auxilium for the Endo deal.<\/p>\n<p style=\"text-align: justify;\">QLT has in its pipeline, the products that focus on development of eye treatments.<\/p>\n<p style=\"text-align: justify;\"><strong>Endo\u2019s Bid for Auxilium <\/strong><\/p>\n<p style=\"text-align: justify;\">Yesterday,\u00a0Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) disclosed the amount of its bid as well. The company said that it was ready to offer $28.10 per share for the acquisition of Auxilium. This will sum up to approximately $2.2 billion in stock and cash. Endo, which is based in Dublin, is looking forward to rope in the male-related healthcare products of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL).<\/p>\n<p style=\"text-align: justify;\"><strong>Bid for Auxilium\u2019s Men\u2019s Health Related Products<\/strong><\/p>\n<p style=\"text-align: justify;\">The prime objective of\u00a0Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) is to get hold of the aforementioned products.\u00a0Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) is maker and marketer of specialized men\u2019s healthcare biopharmaceutical products. Apart from this, through the acquisition deal, Endo will also look forward to extractracting benefit from Auxilium\u2019s expanded pipeline and portfolio of other products like orthopaedics-related and dermatology-related objects.<\/p>\n<p style=\"text-align: justify;\">Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP)\u00a0has already given hints regarding the \u201ccrucial synergy opportunities\u201d that it will extract with this acquisition. It also underscored about the potential growth of Xiaflex drug of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/18\/2014 (wallstreetpr) \u2013 Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) confirmed yesterday that Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) gave an unsolicited buyout offer for [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":31447,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[7603,9320,7604,6277,7606,7605],"stock_ticker":[],"class_list":["post-31442","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-auxilium-pharmaceuticals-inc-nasdaqauxl","tag-endo-international-plc-ordinary-shares-nasdaqendp","tag-nasdaqauxl","tag-nasdaqendp","tag-nasdaqqlti","tag-qlt-inc-usa-nasdaqqlti","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc - Ordinary Shares (NASDAQ:ENDP) Bid - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc - Ordinary Shares (NASDAQ:ENDP) Bid - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/18\/2014 (wallstreetpr) \u2013 Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) confirmed yesterday that Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) gave an unsolicited buyout offer for [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-18T13:17:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"414\" \/>\n\t<meta property=\"og:image:height\" content=\"207\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) Bid\",\"datePublished\":\"2014-09-18T13:17:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442\"},\"wordCount\":393,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg\",\"keywords\":[\"Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL)\",\"Endo International plc - Ordinary Shares (NASDAQ:ENDP)\",\"NASDAQ:AUXL\",\"NASDAQ:ENDP\",\"NASDAQ:QLTI\",\"QLT Inc. (USA) (NASDAQ:QLTI)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442\",\"name\":\"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc - Ordinary Shares (NASDAQ:ENDP) Bid - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg\",\"datePublished\":\"2014-09-18T13:17:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg\",\"width\":414,\"height\":207},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) Bid\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc - Ordinary Shares (NASDAQ:ENDP) Bid - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442","og_locale":"en_US","og_type":"article","og_title":"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc - Ordinary Shares (NASDAQ:ENDP) Bid - Wall Street PR","og_description":"Boston, MA 09\/18\/2014 (wallstreetpr) \u2013 Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) confirmed yesterday that Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) gave an unsolicited buyout offer for [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-18T13:17:19+00:00","og_image":[{"width":414,"height":207,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) Bid","datePublished":"2014-09-18T13:17:19+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442"},"wordCount":393,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg","keywords":["Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL)","Endo International plc - Ordinary Shares (NASDAQ:ENDP)","NASDAQ:AUXL","NASDAQ:ENDP","NASDAQ:QLTI","QLT Inc. (USA) (NASDAQ:QLTI)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442","url":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442","name":"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc - Ordinary Shares (NASDAQ:ENDP) Bid - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg","datePublished":"2014-09-18T13:17:19+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/Auxilium-e1363655487864.jpg","width":414,"height":207},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/auxilium-pharmaceuticals-inc-nasdaqauxl-adopts-shareholder-rights-plan-for-endo-international-plc-ordinary-shares-nasdaqendp-bid-31442#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc &#8211; Ordinary Shares (NASDAQ:ENDP) Bid"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=31442"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31442\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/31447"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=31442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=31442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=31442"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=31442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}